MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
NeoGenomics Cash and Cash Equivalents 2011-2026 | NEO
Annual Cash and Cash Equivalents NeoGenomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 160 M | 367 M | 342 M | 263 M | 317 M | 229 M | 173 M | 9.81 M | 12.8 M | 12.5 M | 23.4 M | 33.7 M | 4.83 M | 1.87 M | 2.63 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 367 M | 1.87 M | 130 M |
Quarterly Cash and Cash Equivalents NeoGenomics
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 146 M | 160 M | 155 M | 346 M | 367 M | 362 M | 355 M | 332 M | 342 M | 306 M | 289 M | 276 M | 263 M | 266 M | 284 M | 306 M | 317 M | 341 M | 369 M | 612 M | 251 M | 229 M | 229 M | 229 M | 173 M | 173 M | 173 M | 173 M | 9.81 M | 9.81 M | 9.81 M | 9.81 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 23.4 M | 23.4 M | 23.4 M | 23.4 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 4.83 M | 4.83 M | 4.83 M | 4.83 M | 1.87 M | 1.87 M | 1.87 M | 1.87 M | 2.63 M | 2.63 M | 2.63 M | 2.63 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 612 M | 1.87 M | 137 M |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Co-Diagnostics
CODX
|
11.9 M | $ 1.29 | -20.86 % | $ 1.72 M |  USA |
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
55.1 M | $ 15.71 | -2.96 % | $ 475 M | USA |
 |
Agilent Technologies
A
|
1.48 B | $ 111.77 | -1.3 % | $ 34 B | USA |
 |
Castle Biosciences
CSTL
|
117 M | $ 19.2 | 1.69 % | $ 557 M | USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
1.13 B | $ 143.1 | -0.1 % | $ 22.8 B | USA |
 |
Interpace Biosciences
IDXG
|
2.5 M | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
65.4 M | $ 20.02 | -2.29 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
2 K | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
359 M | $ 94.21 | -2.55 % | $ 6.36 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
66.9 M | $ 1 034.95 | -0.67 % | $ 21.3 B |  Schweiz |
 |
Medpace Holdings
MEDP
|
497 M | $ 417.68 | -0.36 % | $ 12 B | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M |  China |
 |
Myriad Genetics
MYGN
|
150 M | $ 3.59 | -0.97 % | $ 332 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
214 M | $ 150.9 | -5.17 % | $ 7.48 B | USA |
 |
National Research Corporation
NRC
|
4.14 M | $ 18.56 | -1.95 % | $ 415 M | USA |
 |
Natera
NTRA
|
466 M | $ 188.46 | -4.22 % | $ 18.5 B | USA |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 25.24 | -1.02 % | $ 23.9 B |  Niderland |
 |
Guardant Health
GH
|
378 M | $ 95.46 | -3.24 % | $ 12 B | USA |
 |
Senseonics Holdings
SENS
|
40.2 M | $ 5.76 | -1.12 % | $ 240 M | USA |
 |
Personalis
PSNL
|
124 M | $ 6.4 | -4.69 % | $ 571 M | USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
752 M | $ 115.74 | -1.15 % | $ 9.55 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
70.1 M | $ 53.0 | 0.01 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
2.4 M | $ 2.3 | -4.56 % | $ 5.28 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
532 M | $ 251.69 | -0.92 % | $ 20.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
9.85 B | $ 438.03 | -2.27 % | $ 165 B | USA |
 |
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.56 | -3.63 % | $ 201 M | Irlanda |
 |
Celcuity
CELC
|
166 M | $ 137.57 | 2.12 % | $ 6.43 B | USA |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 49.03 | -7.4 % | $ 2.93 B | USA |
 |
Neogen Corporation
NEOG
|
129 M | $ 8.18 | -3.02 % | $ 1.77 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
420 M | $ 187.21 | -0.39 % | $ 20.8 B | USA |
 |
Waters Corporation
WAT
|
588 M | $ 331.36 | -0.56 % | $ 19.7 B | USA |